Repare Therapeutics Inc. (RPTX) Tops Q2 EPS by 53c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q2 EPS of ($0.28), $0.53 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $30.25 million versus the consensus estimate of $7.01 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c